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ABSTRACT
Introduction: Despite their proven effectiveness in
reducing childhood infectious diseases, the uptake of
vaccines remains suboptimal in low and middle-
income countries. Identifying strategies for transmitting
accurate vaccine information to caregivers would boost
childhood vaccination coverage in these countries.
The purpose of this review is to assess the effects on
childhood vaccination coverage of interventions for
informing or educating caregivers about the
importance of vaccines in low and middle-income
countries, as defined by the World Bank.
Methods and analysis: Eligible study designs
include randomised controlled trials (RCTs) as well as
non-randomised controlled trials (non-RCTs). We will
conduct a comprehensive search of both peer-reviewed
and grey literature available up to 31 May 2015. We
will search PubMed, Scopus, Cochrane Central Register
of Controlled Trials, Web of Science, Cumulative Index
of Nursing and Allied Health, prospective trial registries
and reference lists of relevant publications. Two
authors will independently screen the search output,
retrieve full texts of potentially eligible studies and
assess the latter against predefined inclusion criteria.
Disagreements between the two authors will be
resolved through consensus and arbitration by a third
author. We will pool data from studies with
homogenous interventions and outcomes, using
random-effects meta-analysis. We will assess statistical
heterogeneity using the χ2 test of homogeneity
(with signiﬁcance defined at the 10% α-level) and
quantify it using Higgins’ inconsistency index. We will
explore the cause of any observed statistical
heterogeneity using subgroup analysis, with subgroups
defined by study design (RCTs vs non-RCTs) and type
of intervention (information vs educational
interventions).
Ethics and dissemination: The proposed systematic
review will collect and analyse secondary data that are
not associated with individuals. The review will make a
significant contribution to the knowledge base of
interventions for improving childhood vaccination
coverage in low and middle-income countries.
Protocol registration number: PROSPERO,
CRD42014010141.
INTRODUCTION
The use of vaccines during childhood has
been one of the most effective public health
interventions for combating infectious dis-
eases.1 Vaccination is vital not only in avert-
ing infections, it also mitigates the severity of
disease and prevents some cancers (eg,
cancers of the cervix and liver).2 The
Expanded Programme on Immunisation
(EPI), established in 1974 by the WHO, has
greatly reduced the global burden of polio-
myelitis, measles, tetanus, viral hepatitis B,
diphtheria and other diseases.3 However,
vaccination coverage remains low in
Strengths and limitations of this study
▪ This study will contribute to strengthen the evi-
dence base on effective interventions for improv-
ing immunisation coverage in resource-
constrained settings.
▪ We will use the GRADE system to ascertain the
strength of the evidence base for each outcome
and report data for the primary outcome in a
‘Summary of Findings’ table.
▪ We have written the protocol following the
recently published PRISMA-P guidelines.
▪ We will include non-randomised trials, which are
prone to have a high risk of bias and are likely to
produce evidence of low certainty. To mitigate
this risk, we plan to conduct sensitivity analyses
to assess the robustness of the findings to risk
of bias by excluding studies with a high risk of
bias.
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many low and middle-income countries (LMICs).
As a consequence, millions of children in such countries
still die from diseases that could have been prevented
with vaccines.2
Low immunisation coverage in LMICs has been attrib-
uted to several reasons, including family characteristics,
parental attitudes and knowledge and inadequate
information and communication.4 In particular, poor
understanding of vaccines and vaccination schedules is
associated with low immunisation coverage in LMICs.5
A randomised controlled trial has suggested that care-
giver concerns regarding childhood vaccines may be
due to conﬂicting information parents receive about the
safety and risks of vaccines.6 Therefore, it is important
that caregivers are directed to accurate information so
that they can make informed decisions regarding vaccin-
ation of their child population.6
The use of messages that address caregivers’ concerns
and false beliefs may be an effective method for increas-
ing compliance with vaccination schedules. Healthcare
providers need strategies to successfully transfer
vaccine-related information7 and to deal empathically
and effectively with caregivers who have been exposed to
antivaccination rumours and who question the need to
vaccinate their children.8
Communication between and among providers and
recipients of healthcare services has been highlighted as
an emerging ﬁeld of importance within the healthcare
landscape.9 Active engagement and effective communica-
tion between healthcare providers and recipients are safe
and efﬁcient ways for improving a broad range of health-
care outcomes.10 Informing and educating caregivers
about the beneﬁts of vaccination could empower them to
undertake effective preventive health care in general,
which in turn could increase vaccination coverage.11
Therefore, it is important to identify relevant interven-
tions for informing and educating caregivers about the
importance of childhood vaccination in LMICs.
The purpose of this review is to assess the effects on
vaccination coverage of interventions to inform or
educate caregivers about childhood vaccination in low
and middle-income countries, compared to standard
immunisation practices.
METHODS AND ANALYSIS
The synopsis for this systematic review protocol is registered
in the International Prospective Register of Systematic
Reviews (http://www.crd.york.ac.uk/PROSPERO),12 regis-
tration number CRD42014010141. We will include rando-
mised controlled trials (RCTs), with randomisation at
either individual or cluster level. For cluster RCTs, we will
only include those with at least two intervention and two
control clusters.
In addition, we will include non-randomised con-
trolled trials (non-RCTs), with allocation at either indi-
vidual or cluster level. Non-RCTs are studies that
allocated interventions by alternation between groups,
by the use of birth dates or weekdays, or by other non-
random methods. For cluster non-RCTs, we will only
include those with at least two intervention and two
control clusters. We will include only studies conducted
in low and middle-income countries, as deﬁned by the
World Bank.13
This review will focus on interventions to inform or
educate caregivers about the importance of vaccination.
These interventions may include information sessions,
group classes, oral presentations, slide shows, seminars,
workshops, printed materials (pamphlets, posters and
brochures), audio or video recordings and one-on-one
education. These interventions can be delivered either
face-to-face, by mail (email, letters or postcards), or
through phone calls or mobile phone text messaging.
Interventions aimed at reminding caregivers about vac-
cination sessions for their children, or recalling care-
givers who have missed vaccination visits, are outside the
scope of this review and will be excluded. We will
compare the information on educational interventions
to no intervention, standard immunisation practices in
the study setting, alternative interventions or similar
interventions implemented with different degrees of
intensity.
The participants of interest will be caregivers (deﬁned
as parents, legal guardians or other persons assuming
the parental role) to whom information or education
about vaccination is given.
The primary outcome will be children’s vaccination
status (as deﬁned by the trial authors). Secondary out-
comes include caregivers’ knowledge of vaccination,
caregivers’ intention to vaccinate their children, care-
givers’ satisfaction with the intervention and cost of the
interventions.
We have developed a comprehensive search strategy
for searching peer-reviewed and grey literature (see
online supplementary appendix). Sources of peer-
reviewed literature to be searched include PubMed,
Scopus, Cochrane Central Register of Controlled Trials
(CENTRAL), ISI Web of Science (Science Citation
Index), Cumulative Index of Nursing and Allied Health
(CINAHL) and PDQ Evidence. In addition, we will
search for ongoing trials in the WHO International
Clinical Trials Registry Platform and Clinicaltrials.gov,
and check reference lists of relevant reviews and full-text
articles assessed for eligibility. We will include articles
available by 31 May 2015.
Two review authors will independently screen the
search outputs for potentially eligible studies. Full texts
of potentially eligible studies will be retrieved and the
two authors will independently assess them for eligibility
against the study inclusion criteria. We will endeavour to
translate potentially eligible studies published in lan-
guages other than English and French. Disagreements
about the inclusion of studies will be resolved through
discussion and consensus. If disagreements are not
resolved, a third author will arbitrate. Reasons for
excluding potentially eligible studies will be provided.
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Two authors will independently extract data using a
predesigned pilot-tested data collection form and
compare their results, resolving discrepancies by consen-
sus and arbitration by a third author, as required. The
data to be extracted will include study design and
methods, country setting (including income level as
deﬁned by the World Bank) and participant character-
istics, intervention characteristics, study outcomes and
study funding sources. In cases of missing or incomplete
information in the included studies, we will contact
study authors for further information.
In multicountry studies involving LMICs and also high-
income countries, we will only extract data from LMICs.
However, if data are not reported by country income
levels we will contact the study authors to request separ-
ate data for LMICs. If, by the time the review is pub-
lished, we have not yet received such data, we will classify
the studies as awaiting assessment; and endeavour to
update the systematic review as soon as such data
become available.
The two authors will independently assess the risk of
bias in each included study using the following criteria:
adequacy of random sequence generation and allocation
concealment (for risk of selection bias); blinding of par-
ticipants and personnel (for risk of performance bias);
blinding of outcome assessors (for risk of detection
bias); completeness of outcome data (for risk of attrition
bias); and completeness of outcome reporting (for risk
of reporting bias).14 For each domain, we will classify
the risk of bias as ‘low’ if the criterion was adequately
addressed, ‘unclear’ if the information provided was not
sufﬁcient to make an informed judgement or ‘high’ if
the criterion was not adequately addressed.
We will then summarise the assessments and categor-
ise the included studies into three levels of bias: low,
moderate and high risk of bias. Every study that is classi-
ﬁed as low risk for all domains will be considered to be
at low risk of bias. Any study that has a high risk of selec-
tion, detection or attrition bias, will be categorised as
having a high risk of bias. All other studies will be con-
sidered to have a moderate risk of bias.
We will conduct data analysis using the latest version
of the Cochrane Collaboration Review Manager statis-
tical software (http://ims.cochrane.org/RevMan). Apart
from cost of the intervention, the review outcomes are
most likely to be reported as dichotomous data. We will
express the results of each study as a risk ratio and its
95% CIs (CI for dichotomous outcomes.14
We will pool the RRs and 95% CIs of studies with iden-
tical outcomes and interventions; using random-effects
meta-analysis, because of anticipated heterogeneity of
study designs and participants. We will include data from
eligible cluster RCTs in relevant meta-analyses after con-
trolling for the design effect, using the intracluster cor-
relation coefﬁcient (ICC) derived from the same or a
similar published cluster RCT.15 16
Statistical heterogeneity in each meta-analysis will be
assessed using the χ2 test of homogeneity and quantiﬁed
using the Higgins’ I2 statistic. We will deﬁne statistical het-
erogeneity at the 10% α level; and assess the source of
observed statistical heterogeneity using subgroup analyses.
We will conduct subgroup analysis only for the primary
outcome (ie, vaccination coverage), with subgroups
deﬁned by study design (RCTs vs non-RCTs) and type of
intervention (information vs educational interventions).
We have chosen each subgroup based on a speciﬁc
hypothesis. Non-randomised studies are prone to selec-
tion bias and may over-estimate the efﬁcacy of an inter-
vention. Educational interventions (eg, structured and
interactive communication tools) may lead to a better
understanding of the importance of immunisation by
caregivers and thus be more effective at increasing vaccin-
ation coverage than passive provision of information.17
We will perform a sensitivity analysis to determine the
robustness of the ﬁndings to risk of bias (ie, including and
excluding studies with a high risk of bias); with emphasis
on allocation concealment, blinded outcome assessment
and losses to follow-up (with a cut-off value of 25%).18
We plan to use funnel plots to assess the possibility of
publication bias across studies for every meta-analysis
involving 10 or more studies.16 Publication bias leads to
funnel plot asymmetry; but when there are fewer than
10 studies in a meta-analysis, funnel plot tests are unreli-
able in differentiating between real asymmetry and the
play of chance. Other causes of funnel plot asymmetry
include delayed-publication bias, location bias, selective
outcome reporting, poor methodological design, inad-
equate analysis and fraud.16
We will use the GRADE approach to assess the cer-
tainty of the evidence for each outcome,19 and present
data in forest plots and ‘Summary of Findings’ tables.20
We have written this protocol following the recently
released PRISMA-P guidelines,21 and will report the
review according to the PRISMA statement; including
any available revisions or extended guidance.22 23
ETHICS AND DISSEMINATION
We did not seek ethical approval for this study because
the data to be collected cannot be linked to individuals.
The ﬁndings of the review will make a signiﬁcant contri-
bution to the knowledge base of interventions for
improving childhood vaccination coverage in low and
middle-income countries. The study will gather evidence
on how vaccination information or education impacts
childhood vaccine uptake. We anticipate that this infor-
mation will be useful to national and international stake-
holders interested in improving the performance of
childhood immunisation programmes in low and
middle-income countries.
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